WhitneyH. A. K.Jr.: Community Clinical Pharmacy Practice, Drug Intelligence Clin. Pharm.5: 258 (Aug.) 1971.
2.
HartshornE. A.: Handbook of Drug Interactions, Donald E. Francke, Publisher, Cincinnati, Ohio45–229, p. ii.
3.
GothA.: Medical Pharmacology, ed. 5, The C. V. Mosby Company, St. Louis, Mo., 1970. p. 615–623.
4.
GiletteJ. R.: Factors Affecting Drug Metabolism, Ann. N.Y. Acad.179: 43–66 (July) 1971.
5.
BeekenW. L.: Studies on I131 Albumin Catabolism and Distribution in Normal Young Male Adults. J. Clin. Invest.41: 1312–1333 (June) 1962.
6.
AntonA. H.: The Relation Between the Binding of Sulfonamides to Albumin and their Antibacterial Efficacy, J. Pharmacol. Exp. Therap.129: 282–290 (July) 1960.
7.
KuninC. M.: Clinical Pharmacology of the New Penicillins II: Effect of Drugs which Interfere with Binding to Serum Proteins, Clin. Pharmacol. Therap.7: 180–187 (March-April) 1966.
8.
LofholmP. W.: “The Clinical Pharmacist in General Practice,” in FranckeD. E.WhitneyH. A. K.Jr., eds.: Perspectives in Clinical Pharmacy, Drug Intelligence Publications, Hamilton, Illinois, 62341, 1972 (in press).
9.
RitschelW. A.: Applied Biopharmaceutics I, A Continuing Education Program, College of Pharmacy, University of Cincinnati, 1969, p. 13.
10.
RitschelW. A.: Biopharmaceutics and Future Practice of Pharmacy, Pharma. International1: 1–2, 1971.